Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    UID:
    almafu_BV047270476
    Format: xiv, 510 Seiten : , Illustrationen ; , 24 cm.
    ISBN: 978-981-122-247-4 , 978-981-124-992-1
    Content: What is the Pharmaceutical Industry? -- Regulating Corporate Medicine -- Cells, Germs, Receptors and Magic Bullets : From Ancient to Modern Theories of the Body, Disease, and Drug Action -- From the Dyeing Arts to Drugs : Dye-making, Pharmacy and the new Research Corporation -- Making Hormones -- The Anti-infectives : Sulphonamide, Penicillin and the Antibiotics -- Biotechnology, Personalisation, Precision, and the Digital Turn -- Intellectual Property in Biomedicine -- Prescriptions for a Healthier Pharmaceutical Industry
    Content: "This book is a history of medicines and the commercial actors that make and sell them, covering the 140 years since the modern pharmaceutical industry came into being. It is written in a lively and accessible way, aiming at a general audience that combines historical narrative with fascinating case studies on drug discovery and commercialization, from the rat poison that became warfarin, to a cardiovascular treatment that was turned into Viagra. In a non-partisan way it also examines some of the less noble manifestations of corporate behavior, concluding with an agenda for reform. It is hard to think of anything nobler than to bring to the world a medicine that saves lives. And over 140 years of history, the pharmaceutical industry has produced a range of remarkable products, albeit typically with external scientific and financial support. Making medicines is a very big and profit-driven business, and the industry does not always make the right products for the right people, or at the right prices. The industry wields immense power over lives and economies. How has it risen to this position of dominance? Are the interests of the industry and the public in balance? What should we admire about the industry? What should we criticise and seek to change? The importance of this book lies in the fact that we are all stakeholders in this industry whether or not we own shares, so we all need answers to these questions."
    Note: Includes bibliographical references and index
    Additional Edition: Erscheint auch als Online-Ausgabe ISBN 978-981-122-249-8
    Additional Edition: Erscheint auch als Online-Ausgabe ISBN 978-981-122-248-1
    Language: English
    Subjects: Chemistry/Pharmacy , Medicine
    RVK:
    RVK:
    Keywords: Pharmakologie ; Pharmazeutische Industrie ; Arzneimittel
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. Further information can be found on the KOBV privacy pages